Arena Pharmaceuticals, Inc. (ARNA)

[bc322032]

In a nut shell the news is:

"The PWG reviewed relevant tissues and reported that mammary fibroadenomas were distinguishable from mammary adenocarcinomas. The PWG reported shifts in the numbers of both tumor types from the initial report included in the lorcaserin New Drug Application (NDA) and that adenocarcinomas were no longer numerically higher than the control group in the lorcaserin low- and mid-dose groups."

http://finance.yahoo.com/marketupdate/inplay#arna


$2.00+ in no time IMO